Searched for
AFREZZA
Cipla launches inhalable insulin for diabetes careCipla has launched a new orally inhaled insulin powder for diabetes patients in India. This needle-free alternative to injections offers a ...- Cipla shares in focus after receiving CDSCO nod to launch inhalation insulinCipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers ...
- Stocks in news: Cipla, PC Jeweller, Shriram Finance, Grasim, Gland PharmaCipla said it has received the nod from Central Drugs Standard Control Organisation (CDSCO) for the exclusive distribution and marketing of...
- Cipla gets CDSCO nod to launch inhalation insulinCipla received approval from CDSCO to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers ...
- Cipla’s inhalable insulin fails to get approval for trials on Indian patientsCipla had based its application to the panel on the bioequivalence studies with Exubra, an inhalation drug and device combination that was ...
- The Holy Grail: How Rani Therapeutics Is packing the insulin punch in pillsScientists couldn’t crack the science because enzymes in the stomach break down and digest the proteins, which are therefore not absorbed i...
- Sanofi bets on dengue vaccine, 5 other drugs to bolster India playFrench co plans to bring raft of innovative products, including preventive dengue vaccine; move may improve company’s prospects over its ri...
Load More